日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual Role of NRF2 in Pancreatic Precursor Lesions.

NRF2在胰腺癌前病变中的双重作用

Ichimiya Shu, Ahn Sung Shin, Dixon Maya S, O'Sullivan John P, DeVine Lela C, Chen Alex, Yamamoto Takeo, Oda Yoshinao, Nakamura Masafumi, Chio Iok In Christine

An Iron-regulated Signalling Pathway Controls Adipose Browning and Cancer Cachexia

铁调控信号通路控制脂肪褐变和癌症恶病质

Nam, Jung Seung; Dixon, Maya S; Ahmadi, Pardis; Schilling, Kathrin; Pan, Samuel; Chen, Yuxuan; Yoon, Nal Ae; Sun, Yanping; Lu, Jordan; Ichimiya, Shu; Genkinger, Jeanine M; Caffrey, Thomas C; Klute, Kelsey A; Swanson, Benjamin J; Grandgenett, Paul; Hollingsworth, Michael A; Sugahara, Kazuki; Kluger, Michael D; Ferrante, Anthony; Diano, Sabrina; Chio, Iok In Christine

Corrigendum to "PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor" [Volume 14, Issue 9, September 2021, 101152]

对“PTPN3 是一种新型癌症免疫疗法的潜在靶点,该疗法对肺神经内分泌肿瘤具有 T 细胞活化和直接抑制癌症的双重作用”的更正[第 14 卷,第 9 期,2021 年 9 月,101152]

Koga, Satoko; Onishi, Hideya; Masuda, Shogo; Fujimura, Akiko; Ichimiya, Shu; Nakayama, Kazunori; Imaizumi, Akira; Nishiyama, Kenichi; Kojima, Masayuki; Miyoshi, Kei; Nakamura, Katsuya; Umebayashi, Masayo; Morisaki, Takashi; Nakamurab, Masafumi

FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients

FAM115C可能是一种新型肿瘤抑制因子,与胰腺癌患者生存期延长相关。

Saeki, Kiyoshi; Onishi, Hideya; Koga, Satoko; Ichimiya, Shu; Nakayama, Kazunori; Oyama, Yasuhiro; Kawamoto, Makoto; Sakihama, Kukiko; Yamamoto, Takeo; Matsuda, Ryota; Miyasaka, Yoshihiro; Nakamura, Masafumi; Oda, Yoshinao

Prediction of Negative Outcomes in Non-Surgical Treatment for Appendiceal Abscess in Adults

成人阑尾脓肿非手术治疗不良预后的预测

Sadakari, Yoshihiko; Date, Satomi; Murakami, Soichiro; Ichimiya, Shu; Nishimura, Shiho; Kawaji, Hitomi; Sagara, Akiko; Castillo, Jaymel R; Ishikawa, Mikimasa; Kamimura, Tetsuro; Uchiyama, Akihiko; Nakamura, Masafumi